<div><div><table><tr><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><div><span></span></div></td><td><span>Alphabet Inc.</span></td></tr></table></div></div><ix:continuation><div><span>Equity Investments</span></div><div><span>The carrying value of equity securities is measured as the total initial cost plus the cumulative net gain (loss). Our share of gains and losses, including impairments, are included as a component of other income (expense), net, in the Consolidated Statements of Income. See<span></span> Note 7 for further details on other income (expense), net.</span></div><ix:nonnumeric><div><span>The carrying values for marketable and non-marketable equity securities are summarized below (in millions):</span></div><div><span><br/></span></div><div><table><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td><span>As of December 31, 2021</span></td><td></td><td><span>As of December 31, 2022</span></td></tr><tr><td></td><td><span>Marketable Equity Securities</span></td><td></td><td><span>Non-Marketable Equity Securities</span></td><td></td><td><span>Total</span></td><td></td><td><span>Marketable Equity Securities</span></td><td></td><td><span>Non-Marketable Equity Securities</span></td><td></td><td><span>Total</span></td></tr><tr><td><span>Total initial cost</span></td><td><span>$</span></td><td><span><ix:nonfraction>4,211</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>15,135</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>19,346</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>5,764</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>16,157</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>21,921</ix:nonfraction> </span></td><td></td></tr><tr><td><div><span>Cumulative net gain (loss)</span><span>(1)</span></div></td><td><span><ix:nonfraction>3,587</ix:nonfraction></span></td><td></td><td><span><ix:nonfraction>12,436</ix:nonfraction> </span></td><td></td><td></td><td><span><ix:nonfraction>16,023</ix:nonfraction> </span></td><td></td><td></td><td><span>(<ix:nonfraction>608</ix:nonfraction>)</span></td><td></td><td></td><td><span><ix:nonfraction>12,372</ix:nonfraction> </span></td><td></td><td></td><td><span><ix:nonfraction>11,764</ix:nonfraction> </span></td><td></td></tr><tr><td><span>Carrying value</span></td><td><span>$</span></td><td><span><ix:nonfraction>7,798</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>27,571</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>35,369</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>5,156</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>28,529</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>33,685</ix:nonfraction> </span></td><td></td></tr></table></div><div><span>(1)</span><span>Non-marketable equity securities cumulative net gain (loss) is comprised of $<ix:nonfraction>14.1</ix:nonfraction> billion gains and $<ix:nonfraction>1.7</ix:nonfraction> billion losses (including impairments) as of December 31, 2021 and $<ix:nonfraction>16.8</ix:nonfraction> billion gains and $<ix:nonfraction>4.5</ix:nonfraction> billion losses (including impairments) as of December 31, 2022.</span></div></ix:nonnumeric><div><span>Gains and losses on marketable and non-marketable equity securities</span></div><ix:nonnumeric><div><span>Gains and losses (including impairments), net, for marketable and non-marketable equity securities included in other income (expense), net are summarized below (in millions):</span></div><div><table><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td><span>Year Ended December 31,</span></td></tr><tr><td><span> </span></td><td></td><td><span>2020</span></td><td></td><td><span>2021</span></td><td></td><td><span>2022</span></td></tr><tr><td><span>Realized net gain (loss) on equity securities sold during the period</span></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>1,339</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>1,196</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span>(<ix:nonfraction>442</ix:nonfraction>)</span></td><td></td></tr><tr><td><span>Unrealized net gain (loss) on marketable equity securities</span></td><td></td><td><span><ix:nonfraction>2,722</ix:nonfraction> </span></td><td></td><td></td><td><span><ix:nonfraction>1,335</ix:nonfraction> </span></td><td></td><td></td><td><span>(<ix:nonfraction>3,242</ix:nonfraction>)</span></td><td></td></tr><tr><td><div><span>Unrealized net gain (loss) on non-marketable equity securities</span><span>(1)</span></div></td><td></td><td><span><ix:nonfraction>1,531</ix:nonfraction> </span></td><td></td><td></td><td><span><ix:nonfraction>9,849</ix:nonfraction> </span></td><td></td><td></td><td><span><ix:nonfraction>229</ix:nonfraction> </span></td><td></td></tr><tr><td><span>Total gain (loss) on equity securities in other income (expense), net</span></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>5,592</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>12,380</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span>(<ix:nonfraction>3,455</ix:nonfraction>)</span></td><td></td></tr></table></div><div><span>(1)</span><span>Unrealized gain (loss) on non-marketable equity securities accounted for under the measurement alternative is comprised of $<ix:nonfraction>3.0</ix:nonfraction> billion, $<ix:nonfraction>10.0</ix:nonfraction> billion, and $<ix:nonfraction>3.3</ix:nonfraction> billion of upward adjustments as of December 31, 2020, 2021, and 2022, respectively, and $<ix:nonfraction>1.5</ix:nonfraction> billion, $<ix:nonfraction>122</ix:nonfraction> million, and $<ix:nonfraction>3.0</ix:nonfraction> billion of downward adjustments (including impairments) as of December 31, 2020, 2021, and 2022, respectively.</span></div></ix:nonnumeric><div><span>In the table above, realized net gain (loss) on equity securities sold during the period reflects the difference between the sale proceeds and the carrying value of the equity securities at the beginning of the period or the purchase date, if later. </span></div><ix:nonnumeric><div><span>Cumulative net gains (losses) on equity securities sold during the period, which is summarized in the following table (in millions), represents the total net gains (losses) recognized after the initial purchase date of the equity security sold during the period. While these net gains (losses) may have been reflected in periods prior to the period of sale, we believe they are important supplemental information as they reflect the economic net gains (losses) on the securities sold during the period. Cumulative net gains (losses) are calculated as the difference between the sale price and the initial purchase price for the equity security sold during the period.</span></div><div><table><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td><span>Equity Securities Sold During the Year Ended December 31,</span></td></tr><tr><td><span> </span></td><td><span>2021</span></td><td></td><td><span>2022</span></td></tr><tr><td><span>Total sale price</span></td><td><span>$</span></td><td><span><ix:nonfraction>5,604</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>1,784</ix:nonfraction> </span></td><td></td></tr><tr><td><span>Total initial cost</span></td><td><span><ix:nonfraction>1,206</ix:nonfraction> </span></td><td></td><td></td><td><span><ix:nonfraction>937</ix:nonfraction> </span></td><td></td></tr><tr><td><div><span>Cumulative net gains (losses)</span><span>(1)</span></div></td><td><span>$</span></td><td><span><ix:nonfraction>4,398</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>847</ix:nonfraction> </span></td><td></td></tr></table></div><div><span>(1)</span><span>Cumulative net gains excludes cumulative losses of $<ix:nonfraction>738</ix:nonfraction> million resulting from our equity derivatives, which hedged the changes in fair value of certain marketable equity securities sold during the year ended December 31, 2021. The associated derivative liabilities arising from these losses were settled against our holdings of the underlying equity securities.</span></div></ix:nonnumeric></ix:continuation><div><div><div><span>63</span></div></div></div>